163 related articles for article (PubMed ID: 33993061)
1. MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.
Nejati K; Alivand M; Arabzadeh A
Pathol Res Pract; 2021 Jul; 223():153452. PubMed ID: 33993061
[TBL] [Abstract][Full Text] [Related]
2. microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.
Zhang Q; Lv R; Guo W; Li X
J Cell Biochem; 2019 Jun; 120(6):10370-10379. PubMed ID: 30565744
[TBL] [Abstract][Full Text] [Related]
3. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
Panoutsopoulou K; Avgeris M; Scorilas A
Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2α in Cervical Cancer Under Hypoxic Conditions.
Jiang L; Shi S; Shi Q; Zhang H; Xia Y; Zhong T
Oncol Res; 2018 Aug; 26(7):1055-1062. PubMed ID: 29321085
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
Liang C; Ding J; Yang Y; Deng L; Li X
Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
[TBL] [Abstract][Full Text] [Related]
7. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA
Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765
[TBL] [Abstract][Full Text] [Related]
8. Regulation of breast cancer and bone metastasis by microRNAs.
Vimalraj S; Miranda PJ; Ramyakrishna B; Selvamurugan N
Dis Markers; 2013; 35(5):369-87. PubMed ID: 24191129
[TBL] [Abstract][Full Text] [Related]
9. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
11. Expression of bmi-1 protein in cervical, breast and ovarian cancer.
Gavrilescu MM; Todosi AM; Aniţei MG; Filip B; Scripcariu V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1112-7. PubMed ID: 23700898
[TBL] [Abstract][Full Text] [Related]
12. Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a Systematic Overview.
Thankachan S; Bhardwaj BK; Venkatesh T; Suresh PS
Reprod Sci; 2021 Sep; 28(9):2436-2447. PubMed ID: 33569749
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K
Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.
Ribeiro J; Sousa H
Mol Biol Rep; 2014 Mar; 41(3):1525-31. PubMed ID: 24402874
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA, a Promising Biomarker for Breast and Ovarian Cancer: A Review.
Akram F; Atique N; Haq IU; Ahmed Z; Jabbar Z; Nawaz A; Aqeel A; Akram R
Curr Protein Pept Sci; 2021; 22(8):599-619. PubMed ID: 34102968
[TBL] [Abstract][Full Text] [Related]
17. Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A; O'Toole S; Flavin R; Martin C; Kelly L; Ring M; Finn SP; Barrett C; Loda M; Gleeson N; D'Arcy T; McGuinness E; Sheils O; Sheppard B; O' Leary J
Mol Cancer; 2008 Apr; 7():35. PubMed ID: 18442408
[TBL] [Abstract][Full Text] [Related]
18. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
20. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
